Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 20, 476-479, May 1, 1960]
© 1960 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corey, K. R.
Right arrow Articles by Gross, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corey, K. R.
Right arrow Articles by Gross, J.

Labeled Iodinated Compounds in Tumors and Tissues of C3H Mice after the Injection of I131-labeled Triiodothyronine*

Karin R. Corey{dagger} and Jack Gross{ddagger}

( Department of Anatomy, State University of New York, College of Medicine at New York City, Brooklyn, New York)

Tumor-bearing C3H mice were injected with I131-labeled triiodothyronine and sacrificed at 1, 4, and 8 hours later. The I131-labeled compounds in mammary tumors, mammary gland, muscle, and plasma were separated by paper chromatography.

During the course of this work a previously unidentified contaminant, in the triiodothyronine solution, was identified as 3,3'-diiodothyronine on paper chromatographic evidence.

Triiodothyronine accounted for most of the organic I131 in the tissues and was accompanied by various amounts of iodide. In addition, a compound tentatively identified as 3,3'-diiodothyronine accounted for 10 per cent of the activity in plasma and tumors, and for 4–5 per cent in muscle and mammary gland.

* This investigation was supported by a grant from the United States Atomic Energy Commission under their contract No. At (30-1)-1760.

{dagger} Present address: Department of Physics, Memorial Center, New York, N.Y.

{ddagger} Present address: Experimental Medicine and Cancer Research, Hebrew University, Hadassah Medical School, Jerusalem, Israel.

Received 10/21/59.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1960 by the American Association for Cancer Research.